Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia

NCT00981123 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00981123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00981123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 30, 2009
Completion date
April 30, 2010
Enrollment
500 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia